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Anewborn female infantpresented atbirthwith a congenital,
33 · 25 · 25-mm mass located on the nasal bridge and pro-
truding along the left nasopalpebral region (Fig. 1). The
lesion had never bled and there were no problems associated
with feeding or breathing. Physical examination revealed a
round, solid, nonpulsating, painless tumor covered by
erythematous skin with superficial telangiectasias. This mass
showed no growth or change in size during crying or jugular
vein compression (Furstenberg sign). There were no signs of
visual or airway obstruction. The remainder of the physical
examinationwas unremarkable.
Magnetic resonance imaging (MRI) was requested, and
sagittal MRI reconstruction images showed that the lesion
did not exhibit intracranial extension (Fig. 2).
Based on the clinical appearance of the lesion and lack
of intracranial extension, a presumptive diagnosis of lym-
phangioma of the nasal bridge was established. Serial
ophthalmologic examinations were recommended to
assess any visual impairment.
During the following months, neither rapid growth nor
regression of the lesion was observed, which raised the
first clinical suspicion of a misdiagnosis. The infant was
referred to the Department of Plastic Surgery, and surgi-
cal excision was performed at the age of 18 months
(Fig. 3) to prevent further secondary distortion of the
nasal bridge and visual developmental sequelae.
Pathologic evaluation of the excised mass showed skin
overlying glial tissue positive for glial fibrillary acid pro-
tein (GFAP) and enlarged neurons positive for synapto-
physin (Fig. 4), consistent with neuroglial heterotopia.
At the age of 2.5 years, the child is doing well with no evi-
dence of local recurrence (Fig. 5).
Discussion
Nasal glial heterotopia and nasal glioma are both correct terms1
for the designation of nonhereditary, benign, congenital
malformations embryologically related to encephaloceles.2
Nasal gliomas are rare lesions occurring once in 20,000–
40,000 live births, with a total of 250 cases reported in
the literature since the first description by Reid in 1852.3
Usually, they present at birth or in early childhood2,4–6 as
a mass in or about the nose, and three types of clinical
presentation have been recognized: extranasal (60%),
intranasal (30%), or both (10%).7–9 Clinically, external
nasal gliomas present as masses that do not transillumi-
nate, are not affected by crying or straining, and do not
distend with jugular venous compression (Furstenberg
sign).2 Hypertelorism may be present.2,4,10
The differential diagnosis of a congenital nasal midline
mass is wide and should include neurogenic tumors, ectoder-
mal tumors, mesodermal tumors, and teratomas.2 As stated
above, nasal gliomas represent encephaloceles which have
lost their intracranial connection; however, a fibrous stalk is
found in 15–20% of cases as a relict of this connection.8 In
this respect, it is important to recognize the potential for a
central nervous system or subarachnoid space connection, and
to search carefully for evidence of such a connection during
diagnostic procedures and before initiating treatment.2–4,7–9,11
Therefore, the evaluation of a congenital midline mass must
always include either a computed tomography (CT) or
magnetic resonance imaging (MRI) scan to rule out intracra-
nial extension. MRI offers superior soft-tissue contrast, aid-
ing in the planning of the surgical approach, with the
additional advantage of saving the child from being exposed 1225
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to ionizing radiation.2,3 Incisional or aspiration biopsies are
not recommended as they carry the risk of neurologic
complications, includingmeningitis or damage to functional
brain tissue. The principal differential diagnoses are vascular
tumors, mainly (lympho-) hemangiomas, which represent
the most common vascular tumors in infancy.8 Therefore, as
in our patient, it is not unusual to misdiagnose these
entities.8,12,13 Ultrasound is useful for determining whether
the mass is cystic or solid, and Doppler flow studies can
provide further information regarding the arterial flow
patterns. Unlike hemangiomas, which show high arterial
Doppler flow velocity during the end-diastolic phase, nasal
gliomas demonstrate low arterial flow velocity during the
end-diastolic phase.2
The treatment of nasal glial heterotopia is surgical, and
complete resection is curative. Careful excision is necessary
Figure 2 Magnetic resonance imaging demonstrating the
extracranial nature of the mass
Figure 3 Preoperative viewof the lesion at the age of 18months
Figure 4 Glial fibrillary acid protein (GFAP) immunoreaction
(·400)
Figure 5 At 2.5 years of age, without any evidence of local
recurrence
Figure 1 Prominent nasal mass present at birth
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because recurrences have been found to occur in 4–10% of
patients, most probably as a result of incomplete primary
excision.2
Definitivediagnosis is establishedbypathologic evaluation
of the lesion. The histology of nasal glial heterotopia may be
difficult to identify with hematoxylin and eosin stain alone.
Special stains and immunohistochemistry, such as glial fibril-
lary acid protein (GFAP) immunostain, which enhances the
glial tissue within the background fibrosis, and positive
synaptophysin, which confirms the presence of neuronal
cells, are thusof greatutilitywhenmaking thediagnosis.4
In summary, thegreatestdifficulty inyieldingadiagnosisof
nasal glial heterotopia is not considering this condition. The
potential for an intracranial connection must always be kept
in mind when dealing with a congenital midline mass. MRI
imaging should be requested and preoperative biopsies
avoided.Doppler flowstudies canbe performed todifferenti-
ate noninvasively between nasal gliomas and (lympho-)
hemangiomas. Ultimately, complete surgical excision pro-
videsadefinitivediagnosisandcurative treatment.
References
1 Nicolás-Cerdá M, Sanchez Fernandez de Sevilla C,
Lopez-Ginés C, et al. Nasal glioma or nasal glial
heterotopia? Clin Neuropathol 2002; 21: 66–71.
2 DasguptaN,BentzM.Nasal gliomas: identification and
differentiation fromhemangiomas. JCraniofac Surg2003;
14: 736–738.
3 RouevP,DimovP, ShomovG.Acaseof nasal glioma in a
new-born infant. Int JPediatrOtorhinolaryngol2001;58:
91–94.
4 Penner CR, Thompson LDR. Nasal glial heterotopia:
a clinicopathologic and immunophenotypic analysis of 10
cases with a review of the literature. Ann Diagn Pathol
2003; 7: 354–359.
5 Chang K, Leu Y. Nasal glioma: a case report. Ear Nose
Throat J 2001; 80: 410–411.
6 Penner CR, Thompson LDR. Nasal glial heterotopia.
Ear Nose Throat J 2004; 83: 92–93.
7 Dini M, Lo Russo G, Colafranceschi M. So-called nasal
glioma: case report with immunohistochemical study.
Tumori 1998; 84: 398–402.
8 Hoeger P, Schaefer H, Ussmueller J, et al. Nasal glioma
presenting as capillary haemangioma. Eur J Pediatr 2001;
160: 84–87.
9 Paller AS, Pensler JM, Tomita T. Nasal midline masses
in infants and children. Arch Dermatol 1991; 127:
362–366.
10 Turgut M. Glial heterotopias of the nose. Childs Nerv
Syst 1997; 13: 569.
11 Hughes GB, Shapiro G, Hunt W, et al. The management
of the congenital midline mass – a review. Otolaryngol,
Head Neck Surg 1980; 2: 222–233.
12 Levine MR, Kellis A, Lash R. Nasal glioma
masquerading as a capillary hemangioma. Ophthalmol
Plast Reconstr Surg 1993; 9: 132–134.
13 Oddone M, Granata C, Dalmonte P, et al. Nasal glioma
in an infant. Pediatr Radiol 2002; 23: 104–105.
ª 2009 The International Society of Dermatology International Journal of Dermatology 2009, 48, 1225–1227
Vilarinho et al. Nasal glial heterotopia in a newborn Case report 1227
